CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 164 filers reported holding CARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $59,308 | – | 12,079 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ridgeback Capital Investments L.P. | 622,140 | $10,489,000 | 45.13% |
RHO CAPITAL PARTNERS INC | 2,668,057 | $44,983,000 | 15.47% |
Opaleye Management Inc. | 427,000 | $7,199,000 | 3.01% |
DAFNA Capital Management LLC | 169,331 | $2,855,000 | 2.54% |
Private Capital Advisors, Inc. | 246,850 | $4,162,000 | 1.80% |
WALL STREET ASSOCIATES | 192,300 | $3,242,000 | 0.91% |
SECTORAL ASSET MANAGEMENT INC | 1,212,578 | $20,444,000 | 0.87% |
Virtus ETF Advisers LLC | 17,299 | $292,000 | 0.80% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 618,140 | $10,422,000 | 0.58% |
SPHERA FUNDS MANAGEMENT LTD. | 197,820 | $3,335,000 | 0.49% |